374 related articles for article (PubMed ID: 34281580)
1. Diagnostic evaluation and ablation treatments assessment in hepatocellular carcinoma.
Granata V; Grassi R; Fusco R; Belli A; Cutolo C; Pradella S; Grazzini G; La Porta M; Brunese MC; De Muzio F; Ottaiano A; Avallone A; Izzo F; Petrillo A
Infect Agent Cancer; 2021 Jul; 16(1):53. PubMed ID: 34281580
[TBL] [Abstract][Full Text] [Related]
2. Irreversible electroporation of hepatocellular carcinoma: preliminary report on the diagnostic accuracy of magnetic resonance, computer tomography, and contrast-enhanced ultrasound in evaluation of the ablated area.
Granata V; de Lutio di Castelguidone E; Fusco R; Catalano O; Piccirillo M; Palaia R; Izzo F; Gallipoli AD; Petrillo A
Radiol Med; 2016 Feb; 121(2):122-31. PubMed ID: 26345332
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Gadobenate-Enhanced MRI and Gadoxetate-Enhanced MRI for Hepatocellular Carcinoma Detection Using LI-RADS Version 2018: A Prospective Intraindividual Randomized Study.
Rong D; He B; Tang W; Xie S; Kuang S; Grazioli L; Hussain SM; Yang Y; Wang J
AJR Am J Roentgenol; 2022 Apr; 218(4):687-698. PubMed ID: 34817191
[No Abstract] [Full Text] [Related]
4. Diagnostic Efficacy and Safety of Gadoxetate Disodium vs Gadobenate Dimeglumine in Patients With Known or Suspected Focal Liver Lesions: Results of a Clinical Phase III Study.
Zech CJ; Schwenke C; Endrikat J
Magn Reson Insights; 2019; 12():1178623X19827976. PubMed ID: 30799932
[TBL] [Abstract][Full Text] [Related]
5. Contrast ultrasound in hepatocellular carcinoma at a tertiary liver center: First Indian experience.
Laroia ST; Bawa SS; Jain D; Mukund A; Sarin S
World J Radiol; 2013 Jun; 5(6):229-40. PubMed ID: 23807901
[TBL] [Abstract][Full Text] [Related]
6. Dynamic contrast-enhanced MRI perfusion quantification in hepatocellular carcinoma: comparison of gadoxetate disodium and gadobenate dimeglumine.
Stocker D; Hectors S; Bane O; Vietti-Violi N; Said D; Kennedy P; Cuevas J; Cunha GM; Sirlin CB; Fowler KJ; Lewis S; Taouli B
Eur Radiol; 2021 Dec; 31(12):9306-9315. PubMed ID: 34043055
[TBL] [Abstract][Full Text] [Related]
7. Biologic factors affecting HCC conspicuity in hepatobiliary phase imaging with liver-specific contrast agents.
Kim JY; Lee SS; Byun JH; Kim SY; Park SH; Shin YM; Lee MG
AJR Am J Roentgenol; 2013 Aug; 201(2):322-31. PubMed ID: 23883212
[TBL] [Abstract][Full Text] [Related]
8. Hepatobiliary MR contrast agents in hypovascular hepatocellular carcinoma.
Motosugi U; Bannas P; Sano K; Reeder SB
J Magn Reson Imaging; 2015 Feb; 41(2):251-65. PubMed ID: 25104398
[TBL] [Abstract][Full Text] [Related]
9. Optimal Combination of Features on Gadoxetate Disodium-enhanced MR Imaging for Non-invasive Differential Diagnosis of Hepatocellular Carcinoma: The JAMP-HCC Study.
Ichikawa S; Motosugi U; Morisaka H; Kozaka K; Goshima S; Ichikawa T
Magn Reson Med Sci; 2021 Mar; 20(1):47-59. PubMed ID: 32101818
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of focal nodular hyperplasia with MRI: multicenter retrospective study comparing gadobenate dimeglumine to gadoxetate disodium.
Gupta RT; Iseman CM; Leyendecker JR; Shyknevsky I; Merkle EM; Taouli B
AJR Am J Roentgenol; 2012 Jul; 199(1):35-43. PubMed ID: 22733891
[TBL] [Abstract][Full Text] [Related]
11. The value of gadobenate dimeglumine-enhanced hepatobiliary-phase MR imaging for the differentiation of scirrhous hepatocellular carcinoma and cholangiocarcinoma with or without hepatocellular carcinoma.
Jeon TY; Kim SH; Lee WJ; Lim HK
Abdom Imaging; 2010 Jun; 35(3):337-45. PubMed ID: 19350315
[TBL] [Abstract][Full Text] [Related]
12. Hypervascular hepatocellular carcinomas: detection with gadoxetate disodium-enhanced MR imaging and multiphasic multidetector CT.
Onishi H; Kim T; Imai Y; Hori M; Nagano H; Nakaya Y; Tsuboyama T; Nakamoto A; Tatsumi M; Kumano S; Okada M; Takamura M; Wakasa K; Tomiyama N; Murakami T
Eur Radiol; 2012 Apr; 22(4):845-54. PubMed ID: 22057248
[TBL] [Abstract][Full Text] [Related]
13. Combined computed tomography and magnetic resonance imaging improves diagnosis of hepatocellular carcinoma ≤ 3.0 cm.
Lee CM; Choi SH; Byun JH; Lee SJ; Kim SY; Won HJ; Shin YM; Kim PN
Hepatol Int; 2021 Jun; 15(3):676-684. PubMed ID: 33956288
[TBL] [Abstract][Full Text] [Related]
14. Gadoxetic acid-based hepatobiliary MRI in hepatocellular carcinoma.
Ricke J; Steffen IG; Bargellini I; Berg T; Bilbao Jaureguizar JI; Gebauer B; Iezzi R; Loewe C; Karçaaltincaba M; Pech M; Sengel C; van Delden O; Vandecaveye V; Zech CJ; Seidensticker M
JHEP Rep; 2020 Dec; 2(6):100173. PubMed ID: 33103093
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of tumor response to intra-arterial chemoembolization of hepatocellular carcinoma: Comparison of contrast-enhanced ultrasound with multiphase computed tomography.
Paul SB; Dhamija E; Gamanagatti SR; Sreenivas V; Yadav DP; Jain S; Shalimar ; Acharya SK
Diagn Interv Imaging; 2017 Mar; 98(3):253-260. PubMed ID: 27692674
[TBL] [Abstract][Full Text] [Related]
16. Clinical value of dynamic 3-dimensional contrast-enhanced ultrasound imaging for the assessment of hepatocellular carcinoma ablation.
Wang Y; Jing X; Ding J
Clin Imaging; 2016; 40(3):402-6. PubMed ID: 27133676
[TBL] [Abstract][Full Text] [Related]
17. Role of gadoxetic acid-enhanced liver magnetic resonance imaging in the evaluation of hepatocellular carcinoma after locoregional treatment.
Gatti M; Maino C; Darvizeh F; Serafini A; Tricarico E; Guarneri A; Inchingolo R; Ippolito D; Ricardi U; Fonio P; Faletti R
World J Gastroenterol; 2022 Jul; 28(26):3116-3131. PubMed ID: 36051340
[TBL] [Abstract][Full Text] [Related]
18. Emerging Role of Hepatobiliary Magnetic Resonance Contrast Media and Contrast-Enhanced Ultrasound for Noninvasive Diagnosis of Hepatocellular Carcinoma: Emphasis on Recent Updates in Major Guidelines.
Kim TH; Yoon JH; Lee JM
Korean J Radiol; 2019 Jun; 20(6):863-879. PubMed ID: 31132813
[TBL] [Abstract][Full Text] [Related]
19. Image fusion with volume navigation of contrast enhanced ultrasound (CEUS) with computed tomography (CT) or magnetic resonance imaging (MRI) for post-interventional follow-up after transcatheter arterial chemoembolization (TACE) of hepatocellular carcinomas (HCC): Preliminary results.
Ross CJ; Rennert J; Schacherer D; Girlich C; Hoffstetter P; Heiss P; Jung W; Feuerbach S; Zorger N; Jung EM
Clin Hemorheol Microcirc; 2010; 46(2-3):101-15. PubMed ID: 21135486
[TBL] [Abstract][Full Text] [Related]
20. Arterial subtraction images of gadoxetate-enhanced MRI improve diagnosis of early-stage hepatocellular carcinoma.
Kim DH; Choi SH; Byun JH; Kang JH; Lim YS; Lee SJ; Kim SY; Won HJ; Shin YM; Kim PN
J Hepatol; 2019 Sep; 71(3):534-542. PubMed ID: 31108157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
